2024 |
NovoCure Ltd
|
Chief Operating Officer |
- |
- |
2023 |
NovoCure Ltd
|
Chief Operating Officer |
6.0 M |
-9.9 % |
2022 |
NovoCure Ltd
|
Chief Operating Officer |
6.6 M |
3.7 % |
2021 |
NovoCure Ltd
|
- |
6.4 M |
-7.9 % |
2021 |
NovoCure Ltd
|
Chief Operating Officer |
6.4 M |
-7.9 % |
2020 |
NovoCure Ltd
|
- |
6.9 M |
65.7 % |
2020 |
NovoCure Ltd
|
Chief Operating Officer |
6.9 M |
65.7 % |
2020 |
NovoCure Ltd
|
- |
6.9 M |
65.7 % |
2019 |
NovoCure Ltd
|
- |
4.2 M |
21.3 % |
2019 |
NovoCure Ltd
|
- |
4.2 M |
21.3 % |
2019 |
NovoCure Ltd
|
Chief Financial Officer and Chief Accounting Officer |
4.2 M |
21.0 % |
2018 |
NovoCure Ltd
|
- |
3.5 M |
11.0 % |
2018 |
NovoCure Ltd
|
- |
3.5 M |
11.0 % |
2018 |
NovoCure Ltd
|
Chief Financial Officer and Chief Accounting Officer |
3.5 M |
11.0 % |
2017 |
NovoCure Ltd
|
- |
3.1 M |
-50.2 % |
2017 |
NovoCure Ltd
|
Chief Financial Officer |
3.1 M |
-50.2 % |
2017 |
NovoCure Ltd
|
- |
3.1 M |
-50.2 % |
2016 |
NovoCure Ltd
|
- |
6.3 M |
90.1 % |
2016 |
NovoCure Ltd
|
- |
6.3 M |
90.1 % |
2016 |
NovoCure Ltd
|
Chief Financial Officer |
6.3 M |
90.1 % |
2015 |
NovoCure Ltd
|
- |
3.3 M |
171.8 % |
2015 |
NovoCure Ltd
|
- |
3.3 M |
171.8 % |
2015 |
NovoCure Ltd
|
Chief Financial Officer |
3.3 M |
171.8 % |
2014 |
NovoCure Ltd
|
- |
1.2 M |
- |
2014 |
NovoCure Ltd
|
- |
1.2 M |
- |
2014 |
NovoCure Ltd
|
Chief Financial Officer |
1.2 M |
- |